• Tel: 858.663.9055
  • SeparatorEmail: info@nsjbio.com
  • Tel: 858.663.9055
  • Email: info@nsjbio.com
Home >> Antibodies >> VEGF Receptor 2 Antibody / VEGFR2 Polyclonal Antibody

VEGF Receptor 2 Antibody / VEGFR2 Polyclonal Antibody (RQ4055)

  Catalog No Formulation Size Price (USD)  
Image RQ4055 0.5mg/ml if reconstituted with 0.2ml sterile DI water 100 ug 449
Bulk quote request
VEGF Receptor 2 Antibody in Rat Kidney IHC. Immunohistochemistry staining of FFPE rat kidney tissue with VEGF Receptor 2 Antibody at 1 ug/ml. HIER was performed by steaming tissue sections in pH 6 citrate buffer for 20 min followed by cooling before testing. Distinct brown staining is concentrated in vascular and glomerular-associated structures, with additional labeling visible in portions of the surrounding renal tissue. The localized staining pattern supports tissue detection of VEGFR2 with the VEGFR2 Polyclonal Antibody.
VEGF Receptor 2 Antibody in Mouse Kidney IHC. Immunohistochemistry staining of FFPE mouse kidney tissue with VEGF Receptor 2 Antibody at 1 ug/ml. HIER was performed by steaming tissue sections in pH 6 citrate buffer for 20 min followed by cooling before testing. Brown immunoreactivity is visible throughout renal tubular structures and within glomerular regions, producing a clearly defined staining pattern against the counterstained tissue. This experiment demonstrates mouse tissue recognition with the VEGFR2 Polyclonal Antibody.
VEGF Receptor 2 Antibody with Recombinant Mouse VEGFR2 WB. Western blot testing of recombinant mouse VEGFR2 protein with VEGF Receptor 2 Antibody at 0.5 ug/ml. A strong, discrete band is detected at approximately 180 kDa with minimal additional reactivity. The observed molecular weight is compatible with a glycosylated form of VEGFR2 and provides direct target validation using recombinant receptor protein. This clean target-associated signal supports western blot performance of the VEGFR2 Polyclonal Antibody.
VEGF Receptor 2 Antibody Across Mouse Tissues and Cell Lines WB. Western blot testing with VEGF Receptor 2 Antibody. Lane 1: heart; lane 2: thymus; lane 3: spleen; lane 4: kidney; lane 5: brain; lane 6: lung; lane 7: HEPA1-6 cells; lane 8: NIH 3T3 cells. Multiple VEGFR2-reactive species are visible, including high-molecular-weight bands in the approximately 150-230 kDa region. The page lists approximately 152 kDa for immature, 180-200 kDa for intermediate and 220-230 kDa for mature VEGFR2, consistent with extensive receptor processing and glycosylation. This multi-sample experiment supports western blot detection with the VEGFR2 Polyclonal Antibody.
VEGF Receptor 2 Antibody in NIH 3T3 Cells IF. Immunofluorescence staining of FFPE NIH 3T3 cells with VEGF Receptor 2 Antibody and DAPI nuclear counterstain. HIER was performed by steaming in pH 6 citrate buffer for 20 min. Red VEGFR2 immunofluorescence is distributed through the cell bodies and processes surrounding the blue nuclei, producing clear cellular labeling with comparatively low background. The staining demonstrates cellular detection with the VEGFR2 Polyclonal Antibody.
VEGF Receptor 2 Antibody in MCF7 Cells FACS. Flow cytometry analysis of MCF7 cells with VEGF Receptor 2 Antibody at 1 ug per million cells after blocking with goat sera. Cells alone are shown in red, the isotype control in green and VEGF Receptor 2 Antibody staining in blue. The blue population shows a pronounced rightward fluorescence shift relative to both controls, demonstrating clear antibody-dependent detection of VEGFR2 by flow cytometry with the VEGFR2 Polyclonal Antibody.
VEGF Receptor 2 Antibody in LLC1 Cells FACS. Flow cytometry analysis of LLC1 cells with VEGF Receptor 2 Antibody at 1 ug per million cells after blocking with goat sera. Cells alone are shown in red, the isotype control in green and VEGF Receptor 2 Antibody staining in blue. A substantial rightward shift of the blue population relative to the controls demonstrates antibody-dependent detection of VEGFR2 and provides additional flow cytometry validation for the VEGFR2 Polyclonal Antibody.
Availability 1-3 business days
Species Reactivity Mouse, Rat
Format Antigen affinity purified
Host Rabbit
Clonality Polyclonal (rabbit origin)
Isotype Rabbit IgG
Purity Antigen affinity purified
Buffer Lyophilized from 1X PBS with 2% Trehalose and 0.025% sodium azide
UniProt P35918
Localization Cell junction, cytoplasmic
Applications Western Blot : 0.5-1ug/ml
Immunohistochemistry (FFPE) : 1-2ug/ml
Immunofluorescence (FFPE) : 2-4ug/ml
Flow Cytometry : 1-3ug/million cells
Limitations This VEGF Receptor 2 Antibody / VEGFR2 Polyclonal Antibody is available for research use only.
Review this product on BioCompare and get a $20 Amazon gift card

Related Products

Description

VEGF Receptor 2 Antibody / VEGFR2 Polyclonal Antibody recognizes vascular endothelial growth factor receptor 2, a receptor tyrosine kinase that serves as a principal mediator of VEGF-dependent signaling. VEGFR2 is encoded by the KDR gene in humans and is also designated CD309. The corresponding mouse receptor has historically been called Flk1. VEGFR2 plays a central role in angiogenesis, vascular development and regulation of endothelial cell behavior.

VEGFR2 is a transmembrane receptor composed of an extracellular ligand-binding region, a single membrane-spanning segment and an intracellular split tyrosine kinase domain. Binding of VEGF promotes receptor dimerization and activation of kinase activity, leading to phosphorylation of intracellular tyrosine residues. These sites recruit signaling proteins that connect receptor activation with multiple downstream pathways.

VEGF Receptor 2 signaling regulates endothelial cell proliferation, migration and survival as well as vascular permeability. Important downstream mechanisms include phospholipase C gamma and MAPK/ERK signaling, together with PI3K/AKT and other pathways that coordinate cellular responses to angiogenic stimuli. Through these activities, VEGFR2 contributes to formation and remodeling of blood vessels during development and in adult tissues.

The VEGF-VEGFR2 axis is also important in pathological angiogenesis. Increased VEGF signaling can support formation of tumor-associated vasculature, while abnormal VEGFR2 activity is relevant to disorders involving excessive vascular growth, altered permeability and inflammatory responses. The receptor has consequently become an extensively studied component of cancer biology and anti-angiogenic therapeutic research.

NSJ Bioreagents offers this VEGF Receptor 2 Antibody for research into VEGF signaling, vascular biology and receptor tyrosine kinase regulation. The VEGFR2 Polyclonal Antibody terminology provides the widely recognized abbreviated receptor name and helps distinguish this protein from other VEGF receptor family members.

A VEGF Receptor 2 Antibody provides a polyclonal reagent for investigating this central angiogenic receptor, while a VEGFR2 Polyclonal Antibody supports research into endothelial signaling, vascular development and VEGF-dependent pathways.

For another antibody targeting the same receptor, see our VEGFR2 Antibody / KDR Polyclonal Antibody.

Application Notes

Optimal dilution of the VEGF Receptor 2 Antibody / VEGFR2 Polyclonal Antibody should be determined by the researcher.

Immunogen

A recombinant mouse partial protein corresponding to amino acids A20-L244 was used as the immunogen for the VEGF Receptor 2 Antibody.

Storage

After reconstitution, the VEGF Receptor 2 Antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.

Alternate Names

VEGFR2 antibody, KDR antibody, Vascular Endothelial Growth Factor Receptor 2 antibody, CD309 antibody, Kinase Insert Domain Receptor antibody

Cross
Bulk Quote Request Form
Name*:
Organization*:
Email*:
Phone Number*:
Catalog No.*:
Comments and Specifics(amount, formulation, etc.)*:
Validation code: Captchapackage Image


Can't read the image? click here to refresh.
    *required field

Your bulk quote request has been submitted successfully!

Please contact us if you have any questions.